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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S160need revision later; overall health); support during recovery (3 items:
length of recovery; doctors’ recommendations; availability of
resources); and others’ opinions (3 items: surgery as last resort;
friends’/family's recommendations; considerations about others).
Controlling for age and education, results from the multiple linear
regression model suggested that women rated risks/beneﬁts (p¼0.01),
indications (p¼0.02), and support during recovery (p¼0.002) as more
important in TJA decision making than did men, but rated ‘others’
opinions’ similarly (p¼0.35).
Conclusions: Our results identiﬁed the importance of information about
TJA in four distinct domains: indications for TJA, risks and beneﬁts of
surgery, support during recovery, and others’ opinions. Further, our
ﬁndings indicate that, after controlling for age and level of education,
gender differences exist in TJA information needs. These ﬁndings will be
useful to inform TJA education and patient-physician decision making.
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USE OF DRUG COMBINATIONS IN PATIENTS WITH OSTEOARTHRITIS:
A POPULATION-BASED COHORT STUDY
D. Prieto-Alhambra y,z, N. Wilson x. yBotnar Res. Ctr., Univ. of Oxford,
Oxford, United Kingdom; zMRC Lifecourse Epidemiology Unit, Univ. of
Southampton, Southampton, United Kingdom; x Inst. of Bone and Joint
Res., Kolling Inst. of Med. Res., Royal North Shore Hosp., Sydney, Australia
Purpose: Patients affected with osteoarthritis (OA) use different drugs
in search for relief, with potential impact on patients’ safety and
healthcare costs. However, the use of drug combinations in these
patients has not been explored in detail.
We used a large database including primary care medical records and
pharmacy invoice data to explore use of the following drugs in OA
patients in the period 2006-2010: non-steroidal anti-inﬂammatory
drugs (NSAIDs), Symptomatic Slow Acting Drugs for OA (SYSADOA),
COX-2 inhibitors (COX2i), opioids, and other analgesics (paracetamol
and metamizol).
Methods: - Study population and setting: We screened the SIDIAP
Database (www.sidiap.org) to identify those aged 40 years or older with
a new diagnosis of OA using ICD-10 codes. Among these, we ascertained
prevalence of use of oral NSAIDs, COX2i, SYSADOA, opioids, and anal-
gesics (all alone and in combination) in the period 2006-2011.
- Source of data: SIDIAP contains anonymised medical records
and pharmacy invoice data of a representative >5 million
people in Catalonia (North-East Spain).
- Statistical analyses: We estimated prevalence (and 99% Conﬁ-
dence Intervals) of use of these drugs and their combinations,
and the proportion of occasional (MPR25%) and regular
(MPR50%) users for each of them.
Results: We identiﬁed 281,356 patients with an incident clinical diag-
nosis of OA. Among these, 128,314(45.6%) were treated with 3 or more
drugs, and 57,835(20.6%) with no subsidized drugs.
The 3 most common combinations of drugs were: oral NSAID+analgesic
(12.2%); 2.topical NSAID+analgesic (2.5%); and oral NSAID+SYSADOA
(1.8%). Besides, 34,672(12.3%) patients received only 1 drug, the 3 most
common being, in descending order: oral NSAID, analgesic and SYSADOA.
The proportions of occasional and regular users were highest for SYSA-
DOA (24.5% occasional and 6.9% regular users), and lowest for opioidsĂ(7.3% occasional and 1.9% regular users). Proportions (%) of occasional
and regular users for each drug of study are presented in Figure.
Conclusions: About 75% of OA patients are treated with at least 2 drugs,
and more than half receive 3 or more. However, compliance with these
drugs is very low, and hence consequences of polymedication on
effectiveness and safety are difﬁcult to predict as based on clinical trials
results.
These data are of interest for health care provision for patients with OA.
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THE CONSULTATION PREVALENCE OF OSTEOARTHRITIS 2030 MAY
INCREASE BY 50%: PROGNOSIS FOR SWEDEN
A. Turkiewicz y, I.F. Petersson y, J. Björk z, L.E. Dahlberg y, M.
Englund y,x. yDept. of Orthopedics, Clinical Sci. Lund, Lund, Sweden;
zDiv. of Occupational and Environmental Med., Lund Univ., Lund,
Sweden; xClinical Epidemiology Res. and Training Unit, Boston Univ. Sch.
of Med., Boston, MA, USA
Purpose: To project the future consultation prevalence of osteoarthritis
(OA) in the knee, hip and hand.
Methods: The Skåne Health Care Register (SHCR) is a legislative,
mandatory register in Skåne County, Sweden (total population 1.3
million), based on physicians’ International Classiﬁcation of Diseases
(ICD) 10 diagnostic codes. We used observational data on the consul-
tation prevalence of the knee OA (M17), hip OA (M16) and hand/wrist
OA (M15.1, M15.2, M18, M19.0D, M19.1D, M19.2D) by the 31st Dec 2011Figure 1. The prognosis of OA consultation prevalence in knee, hip and hand in
Swedish adults (aged 20+).
Table 1
Variables OR (95% CI)
Standardized log uC2C/sCPII (SD¼1) 2.41 (1.47, 3.95)
Lateral tibiofemoral tenderness absent Reference
Lateral tibiofemoral tenderness present 0.39 (0.16, 0.98)
Age 40-49 Reference
Age 50-59 2.50 (0.96, 6.55)
Age 60+ 5.93 (1.74, 20.20)
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scenarios to the age-speciﬁc (age 20-65 and >65 years) population
structure prognosis for Skåne provided by Statistics Sweden. In scenario
1 (conservative) we assumed that the age-speciﬁc prevalence would
remain constant. In scenario 2 we assumed that the age-speciﬁc prev-
alence of knee OA would increase relatively by 2.6% per year in the ﬁrst
10 years and by 2% per year in the next 10 years for those aged 65 and
by 1.6% per year in the ﬁrst 10 years and by 1.2% per year in the next 10
years for the population >65. Initial values for that increase are based
on the previously published changes in the prevalence of arthritis
between 1994 and 2002 in Canada (Perrucio et al 2006). The reasons for
this observed increase are not fully understood but the increase in
obesity is the main plausible cause. For the OA in the hip or hand we
used half of the increase for knee OA because the impact of the increase
in body mass index on the consultation prevalence in those sites is
probably lower.
Results: In the conservative scenario, which solely depends on changes
in age distribution of the population, the consultation prevalence of
knee OA in adults (aged 20+) will increase from 9.0% in 2011 to 9.9% in
2030, hip OA from 4.0% in 2011 to 4.6% in 2030 and the consultation
prevalence of hand OA in from 2.7% in 2011 to 3.0% in 2030 (Figure).
Assuming the second scenario, i.e., an increase in age-speciﬁc preva-
lence, the consultation prevalence of knee, hip and hand OA in adults
will increase to 13.6%, 5.3% and 3.5% in 2030, respectively. Over a 20-
year period, this corresponds to a relative increase in prevalence of
subjects who have consulted due to OA by 51% for the knee, 32% for the
hip, and 29% for hand OA.
Conclusions: There is a likely scenario for a 30% to 50% increase in OA
consultation prevalence in 20 years from now. Results suggest that
ﬁghting the negative impact of potentially modiﬁable risk factors such
as obesity and injury will be of primary importance to reduce the
occurrence of the OA in the future.303
ASSOCIATIONS OF CLINICAL AND BIOMARKER VARIABLES WITH
CARTILAGE DAMAGE IN PAINFUL PRE-RADIOGRAPHIC KNEE
OSTEOARTHRITIS. RESULTS FROM A POPULATION-BASED STUDY
J. Cibere y,z, E.C. Sayre z, J.M. Esdaile y,z, A. Thorne y, J.A. Kopec y,z,
J. Singer y, S. Nicolaou y, P. Garnero x, A.R. Poole k, V.B. Kraus {,
T. Saxne #, H. Wong y, A. Guermazi; yy. yUniv. of British Columbia,
Vancouver, BC, Canada; zArthritis Res. Ctr. of Canada, Richmond, BC,
Canada; x INSERM Res. Unit 1033 and Cisbio bioassays, Lyon, France;
kMcGill Univ., Montreal, QC, Canada; {Duke Univ., Durham, NC, USA;
# Lund Univ., Lund, Sweden; yyBoston Univ., Boston, MA, USA
Objectives: To evaluate the association of clinical and biomarker vari-
ables with cartilage damage in subjects with knee pain and no radio-
graphic OA
Methods: Subjects with knee pain, age 40-79, stratiﬁed by age decade
and gender, were recruited in a cross-sectional population-based study.
Subjects were evaluated clinically, with MRI, x-ray and biomarkers. MRI
of cartilage (MRC) was scored 0-4 on six knee joint surfaces. Cartilage
damage was deﬁned as MRC2 at any joint site. X-rays were read using
Kellgren-Lawrence (KL) 0-4 grading. Urine biomarkers included C-
telopeptide of type II collagen (uCTX-II) (Nordic Bioscience), type II and
type I and II collagen cleavage neoepitopes (uC2C, uC1,2C) (Ibex), N-
telopeptide of type I collagen (uNTX-I) (Ostex). Serum biomarkers
included sC1,2C, sC2C, c-propeptide of type II procollagen (sCPII), 846
epitope (sCS846) (Ibex), cartilage oligomeric matrix protein (sCOMP)
(AnaMar) and hyaluronic acid (sHA) (Corgenix). Ratios of type II
collagen degradation with synthesis markers were also evaluated.
Biomarker data were log transformed. Clinical variables included pain
duration, pain frequency, WOMAC pain severity, age, gender, BMI,
smoking, knee examinations, history of meniscectomy and knee injury.
Only subjects with normal x-rays (KL<2) were included in this analysis.
Univariate logistic regression analysis was performed initially. Variables
with p<0.25 in univariate analysis were entered into a forward step-
wise multivariable logistic regression analysis. All analyses utilized
stratum sampling weights.
Results: Of 255 subjects, 152 (59.6%) had KL grade <2 and were
included in the analysis. Of these, 78.1% had cartilage damage. Mean age
was 53.7 years, mean BMI 25.9, 53% were female, 15.9% had history of
severe injury requiring a walking aid, 1% had meniscectomy. Results for
the multivariable logistic regression analysis are shown in Table 1. The
risk of cartilage damage was signiﬁcantly increased in those with anincrease in uC2C/sCPII ratio. Other biomarkers were not signiﬁcant. Age
was also associatedwith cartilage damagewith a signiﬁcantly increased
risk in the 60+ age group (OR 5.93; 95% CI 1.74, 20.20) and a trend
towards signiﬁcance in the 50-59 year old age group (OR 2.50; 95% CI
0.96, 6.55). The presence of lateral tibiofemoral tenderness on knee
examination was associated with a signiﬁcantly reduced risk of carti-
lage damage on MRI (OR 0.39; 95% CI 0.16, 0.98).Conclusions: In this population-based study of symptomatic subjects
with no radiographic OA, the ratio of uC2C/sCPII and older age were
associated with an increased risk of cartilage damage, while lateral
tibiofemoral tenderness was associated with a reduced risk of cartilage
damage. Lateral tenderness likely relates to periarticular pain
syndromes and hence may be helpful in ruling out the presence of
cartilage damage in those with knee pain. These ﬁndings may be useful
for future studies aimed at identifying cohorts with early knee OA for
epidemiologic research or clinical trials.
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ADDING VALUE IN KNEE ARTHROPLASTY: ROLE OF SEX AND
OBESITY ON PHYSICAL ACTIVITY POST SURGERY
E. Losina, J. Collins, R.J. Wright, R. Ghazinouri, L. Donnell-Fink,
J.N. Katz. Brigham and Women's Hosp., Boston, MA, USA
Purpose: Over 620,000 total knee arthroplasties (TKAs) are performed
annually in the US. Approximately 80% of TKA recipients achieve the
primary goal of relieving pain and improving functional status. Given the
rich evidence documenting the beneﬁts of physical activity (PA), TKA
recipients could further improve their post-operative outcomes and
quality of life by beingmore physically active. There has been little study
of compliance with PA guidelines in persons who have had TKA, and
factors inﬂuencing compliance with PA guidelines in this population.
Methods: We used data from a randomized controlled trial of the
efﬁcacy of post-TKA patient navigation conducted at a tertiary medical
center. Consecutive subjects undergoing TKA for the primary diagnosis
of knee OA were offered participation in the study, and those who
agreed were followed with surveys preoperatively and at 3 and 6
months postoperatively. Preoperatively, we collected data on demo-
graphic and baseline clinical characteristics, including age, sex and
obesity as well as self-efﬁcacy and pain catastrophizing. At each
assessment study participants reported pain and functional status
(measured by WOMAC). At the 3 and 6 month survey we included the
Yale Physical Activity Survey to ascertain patients’ engagement in
vigorous physical activity and leisure walking. We estimated the
proportion of TKA recipients who achieved the level of PA speciﬁed by
federal PA guidelines based upon their response to Yale PA Survey
questions about vigorous activity. We examined associations between
age, sex and obesity and the likelihood of non-compliance with PA
guidelines. In addition we examined whether pain catastrophizing and
self-efﬁcacy inﬂuenced compliance with PA guidelines.
Results: The study sample consisted of 113 participants, 60% females,
mean age 67.3 years (SD 8.5) and mean BMI 30.3 (SD 6.4). At three
months post-TKA, about 20% of subjects reported amounts of vigorous
PA consistent with PA guidelines, and at six months 35% of TKA recip-
ients were compliant with PA guidelines. At six months, median time of
vigorous PA was 30 min/week (IQR: 10-120 min/week), and differed
greatly between men (70 min/week) and women (30 min/week,
p¼0.0117). The median time engaged in leisure waking was 70 minutes
per week (IQR 22-120 min/week), which was similar for men and
women. Results of multivariate analysis that included age, gender,
obesity, pain status, pain catastrophizing and self-efﬁcacy revealed that
obesity was the only factor independently associated with greater
likelihood of failure to achieve PA guidelines (OR 3.4, 95%CI: 1.37, 8.36).
